TuHURA Biosciences Inc (HURA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $84.76M
Last updated: Nov 17, 2026 at 4:26 PM ET
TuHURA Biosciences Inc (HURA) Stock Chart
TuHURA Biosciences (HURA) has a latest price of $1.40 on Nov 17, 2026, 59.2% below its 52-week high of $3.43. Its price fell 31.7% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 65.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $81,993.01 in Jan 2017 and its lowest $0.54 in Jan 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart HURA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for HURA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 38.6%, and over 6 months it fell 43.1%. The month-end price fell 92.8% over the 3 years through Oct 2026, a compound annual decline of 58.4%.
| Period | Change |
|---|---|
| 1 month | -21.3% |
| 3 months | -38.6% |
| 6 months | -43.1% |
| 12 months | -31.7% |
| 12 months, with dividends | -31.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -92.8% | -58.4% |
| 5 years | -99.9% | -73.7% |
| 10 years | -100.0% | -65.5% |
Price by Year
Its best calendar year was 2020, when the price rose 85.5%, and its weakest was 2023, when it fell 97.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.93 | +155.1% |
| 2025 | $0.76 | -81.5% |
| 2024 | $4.09 | -31.0% |
| 2023 | $5.93 | -97.5% |
| 2022 | $240.91 | -73.0% |
| 2021 | $891.61 | -60.2% |
| 2020 | $2,237.76 | +85.5% |
| 2019 | $1,206.29 | -79.8% |
| 2018 | $5,977.27 | -68.6% |
| 2017 | $19,055.94 | -65.8% |
Trading Range
The price is 25.8% below its 50-day average of $1.89 and 30.9% below its 200-day average of $2.03.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.40 | |
| 52-week high | $3.43 | -59.2% |
| 52-week low | $0.41 | +241.5% |
| 50-day average | $1.89 | -25.8% |
| 200-day average | $2.03 | -30.9% |
Price Risk
Over 3 years, its largest fall from a peak was 96.8%.
| Measure | Value |
|---|---|
| 1-year beta | 2.82 |
| Largest fall, 1 year | -78.9% |
| Largest fall, 3 years | -96.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About HURA
What is HURA's 1-year price change?
TuHURA Biosciences's price fell 31.7% over the past 12 months. With dividends included, the 12-month total return was -31.7%.
What is HURA's 5-year price change?
TuHURA Biosciences's month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 73.7%. These figures leave out dividends.
What is HURA's 52-week high and low?
TuHURA Biosciences's 52-week high is $3.43 and its 52-week low is $0.41. Its latest price of $1.40 on Nov 17, 2026 is 59.2% below the high.
What is HURA's beta?
TuHURA Biosciences's 1-year beta against the S&P 500 is 2.82, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 78.9%.
Is the HURA chart free?
Yes. Advanced Charting for HURA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
HURA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors